Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wagenmann

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|April 15, 2011
Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadineAlina F Dumitru, Mohamed Shamji, Martin Wagenmann, et al.
The World Allergy Organization Journal|May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statementGlenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Allergologie Select|November 27, 2024
Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactionsUta Jappe, Karl-Christian Bergmann, Folke Brinkmann, et al.
Allergo Journal International|February 21, 2017
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC)Ludger Klimek, Karl-Christian Bergmann, Tilo Biedermann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 11, 2012
Vascularised local and free flaps in anterior skull base reconstructionThomas K Hoffmann, Nicolai El Hindy, Oliver M Müller, et al.
British Journal of Clinical Pharmacology|May 8, 2024
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trialClaire Emson, Joseph K Han, Claire Hopkins, et al.
Allergologie Select|January 11, 2021
Biologics for atopic diseases: Indication, side effect management, and new developmentsUta Jappe, Hendrik Beckert, Karl-Christian Bergmann, et al.
International Forum of Allergy & Rhinology|February 21, 2021
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polypsClaire Hopkins, Martin Wagenmann, Claus Bachert, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|April 15, 2011
Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadineAlina F Dumitru, Mohamed Shamji, Martin Wagenmann, et al.
The World Allergy Organization Journal|May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statementGlenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Allergologie Select|November 27, 2024
Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactionsUta Jappe, Karl-Christian Bergmann, Folke Brinkmann, et al.
Allergo Journal International|February 21, 2017
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC)Ludger Klimek, Karl-Christian Bergmann, Tilo Biedermann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polypsLarry Borish, Noam A Cohen, Geoffrey Chupp, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 11, 2012
Vascularised local and free flaps in anterior skull base reconstructionThomas K Hoffmann, Nicolai El Hindy, Oliver M Müller, et al.
British Journal of Clinical Pharmacology|May 8, 2024
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trialClaire Emson, Joseph K Han, Claire Hopkins, et al.
Allergologie Select|January 11, 2021
Biologics for atopic diseases: Indication, side effect management, and new developmentsUta Jappe, Hendrik Beckert, Karl-Christian Bergmann, et al.
International Forum of Allergy & Rhinology|February 21, 2021
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polypsClaire Hopkins, Martin Wagenmann, Claus Bachert, et al.
Pageof 9